Xencor Cash Flow Statement
NASDAQ: XNCRHealthcareBiotechnologyUSD
24.63+0.13 (+0.53%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Xencor free cash flow
In fiscal 2025, Xencor generated -$135.1 million of operating cash flow and spent $3.1 million on capital expenditures. That left free cash flow of -$138.3 million, a free-cash-flow margin of -110.1% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Xencor cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -92.14M | -236.54M | -133.30M | -55.18M | 82.63M | -69.33M | 26.88M | -70.41M | -38.49M | 45.13M |
| Net Income growth (YoY) | — | — | — | -166.78% | — | -357.98% | — | — | -185.29% | — |
| Depreciation & Amortization | 10.51M | 12.11M | 11.50M | 8.80M | 7.49M | 5.79M | 4.30M | 3.25M | 2.03M | 1.47M |
| Stock-Based Compensation | 43.23M | 53.28M | 53.76M | 48.91M | 36.98M | 31.62M | 31.85M | 20.55M | 13.65M | 7.85M |
| Change in Working Capital | 48.02M | -34.02M | 3.28M | -10.97M | -116.97M | 58.82M | 5.28M | -32.74M | -12.80M | 39.08M |
| Operating Cash Flow | -135.12M | -202.19M | -77.93M | 24.48M | -16.85M | -5.00M | 64.37M | -79.76M | -33.60M | 95.24M |
| Capital Expenditures | -3.15M | -6.10M | -18.45M | -38.49M | -13.30M | -10.54M | -7.35M | -7.21M | -5.31M | -1.51M |
| Investing Cash Flow | 139.99M | -7.87M | -111.06M | -119.72M | -46.25M | 100.19M | -50.97M | -164.77M | 31.86M | -214.27M |
| Financing Cash Flow | 8.23M | 197.15M | 189.22M | 5.70M | 43.04M | 18.04M | 10.66M | 254.24M | 3.73M | 120.97M |
| Net Change in Cash | 13.10M | -12.91M | 228.00K | -89.54M | -20.06M | 113.23M | 24.07M | 9.72M | 2.00M | 1.94M |
| Free Cash Flow | -138.27M | -208.28M | -96.37M | -14.01M | -30.15M | -15.54M | 57.02M | -86.97M | -38.91M | 93.73M |
This table shows 10 annual periods of Xencor's cash flow statement, from FY 2025 back to FY 2016, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow XNCR's reporting calendar. What is a cash flow statement?